PDB Short entry for 5VEW HEADER SIGNALING PROTEIN 05-APR-17 5VEW TITLE STRUCTURE OF THE HUMAN GLP-1 RECEPTOR COMPLEX WITH PF-06372222 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,ENDOLYSIN CHIMERA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GLP-1R,LYSIS PROTEIN,LYSOZYME,MURAMIDASE,GLP-1R; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: GLP1R; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, CLASS B, 7TM DOMAIN, TREATMENT OF TYPE 2 DIABETES, SIGNALING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.SONG,D.YANG,Y.WANG,C.D.GRAAF,Q.ZHOU,S.JIANG,K.LIU,X.CAI,A.DAI, AUTHOR 2 G.LIN,D.LIU,F.WU,Y.WU,S.ZHAO,L.YE,G.W.HAN,J.LAU,B.WU,M.A.HANSON,Z.- AUTHOR 3 J.LIU,M.-W.WANG,R.C.STEVENS REVDAT 4 04-OCT-23 5VEW 1 SEQADV REVDAT 3 14-JUN-17 5VEW 1 JRNL REVDAT 2 31-MAY-17 5VEW 1 JRNL REVDAT 1 24-MAY-17 5VEW 0 JRNL AUTH G.SONG,D.YANG,Y.WANG,C.DE GRAAF,Q.ZHOU,S.JIANG,K.LIU,X.CAI, JRNL AUTH 2 A.DAI,G.LIN,D.LIU,F.WU,Y.WU,S.ZHAO,L.YE,G.W.HAN,J.LAU,B.WU, JRNL AUTH 3 M.A.HANSON,Z.J.LIU,M.W.WANG,R.C.STEVENS JRNL TITL HUMAN GLP-1 RECEPTOR TRANSMEMBRANE DOMAIN STRUCTURE IN JRNL TITL 2 COMPLEX WITH ALLOSTERIC MODULATORS. JRNL REF NATURE V. 546 312 2017 JRNL REFN ISSN 0028-0836 JRNL PMID 28514449 JRNL DOI 10.1038/NATURE22378 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 34592 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1743 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.78 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.00 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2583 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2340 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2463 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.65 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 120 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6607 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 222 REMARK 3 SOLVENT ATOMS : 20 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 103.6 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.84450 REMARK 3 B22 (A**2) : 0.78420 REMARK 3 B33 (A**2) : -1.62870 REMARK 3 B12 (A**2) : -0.10260 REMARK 3 B13 (A**2) : 0.32490 REMARK 3 B23 (A**2) : 1.07520 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.510 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.510 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.284 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.609 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.300 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6986 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 9478 ; 2.500 ; HARMONIC REMARK 3 TORSION ANGLES : 3141 ; 15.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 107 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1026 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6986 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 912 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8153 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.47 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 1.54 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|136 - A|1204} REMARK 3 ORIGIN FOR THE GROUP (A): 6.0874 27.2144 26.7189 REMARK 3 T TENSOR REMARK 3 T11: -0.4002 T22: 0.3705 REMARK 3 T33: -0.3146 T12: -0.0256 REMARK 3 T13: 0.0037 T23: 0.0585 REMARK 3 L TENSOR REMARK 3 L11: 1.8680 L22: 0.7690 REMARK 3 L33: 3.2023 L12: 0.0540 REMARK 3 L13: 0.8084 L23: 0.2708 REMARK 3 S TENSOR REMARK 3 S11: 0.1159 S12: 0.3413 S13: 0.1598 REMARK 3 S21: -0.0890 S22: 0.0316 S23: 0.0926 REMARK 3 S31: -0.3653 S32: 0.1221 S33: -0.1476 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|136 - B|1205} REMARK 3 ORIGIN FOR THE GROUP (A): 38.4999 14.8108 56.7418 REMARK 3 T TENSOR REMARK 3 T11: -0.3838 T22: 0.3208 REMARK 3 T33: -0.2916 T12: -0.1007 REMARK 3 T13: -0.0443 T23: 0.0682 REMARK 3 L TENSOR REMARK 3 L11: 1.5942 L22: 0.8210 REMARK 3 L33: 3.9095 L12: 0.0002 REMARK 3 L13: -0.7090 L23: 0.3299 REMARK 3 S TENSOR REMARK 3 S11: 0.1663 S12: -0.2647 S13: -0.1263 REMARK 3 S21: 0.0793 S22: 0.0607 S23: 0.0881 REMARK 3 S31: 0.3669 S32: -0.0865 S33: -0.2271 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VEW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227322. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34615 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB 5EE7 AND 212L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.4-0.45 M AMMONIUM ACETATE, 0.1 M REMARK 280 SODIUM CACODYLATE, PH 6.2-6.6, 35-38% PEG400, 3% W/V REMARK 280 AMINOHEXANOIC ACID, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 127 REMARK 465 GLU A 128 REMARK 465 SER A 129 REMARK 465 LYS A 130 REMARK 465 ARG A 131 REMARK 465 GLY A 132 REMARK 465 GLU A 133 REMARK 465 ARG A 134 REMARK 465 SER A 135 REMARK 465 MET A 211 REMARK 465 GLY A 212 REMARK 465 SER A 213 REMARK 465 GLY A 214 REMARK 465 ASP A 215 REMARK 465 GLY A 216 REMARK 465 LEU A 217 REMARK 465 GLU A 373 REMARK 465 HIS A 374 REMARK 465 ALA A 375 REMARK 465 ARG A 376 REMARK 465 GLY A 377 REMARK 465 THR A 378 REMARK 465 LEU A 379 REMARK 465 GLU A 423 REMARK 465 HIS A 424 REMARK 465 LEU A 425 REMARK 465 HIS A 426 REMARK 465 ILE A 427 REMARK 465 GLN A 428 REMARK 465 ARG A 429 REMARK 465 ASP A 430 REMARK 465 SER A 431 REMARK 465 SER B 127 REMARK 465 GLU B 128 REMARK 465 SER B 129 REMARK 465 LYS B 130 REMARK 465 ARG B 131 REMARK 465 GLY B 132 REMARK 465 GLU B 133 REMARK 465 ARG B 134 REMARK 465 SER B 135 REMARK 465 MET B 211 REMARK 465 GLY B 212 REMARK 465 SER B 213 REMARK 465 GLY B 214 REMARK 465 ASP B 215 REMARK 465 ASP B 372 REMARK 465 GLU B 373 REMARK 465 HIS B 374 REMARK 465 ALA B 375 REMARK 465 ARG B 376 REMARK 465 GLY B 377 REMARK 465 THR B 378 REMARK 465 LEU B 379 REMARK 465 GLU B 423 REMARK 465 HIS B 424 REMARK 465 LEU B 425 REMARK 465 HIS B 426 REMARK 465 ILE B 427 REMARK 465 GLN B 428 REMARK 465 ARG B 429 REMARK 465 ASP B 430 REMARK 465 SER B 431 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 136 OG REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 GLU A 139 CG CD OE1 OE2 REMARK 470 GLN A 140 CG CD OE1 NE2 REMARK 470 LEU A 141 CG CD1 CD2 REMARK 470 LEU A 142 CG CD1 CD2 REMARK 470 ARG A 170 CG CD NE CZ NH1 NH2 REMARK 470 TRP A 203 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 203 CZ3 CH2 REMARK 470 GLN A 221 CG CD OE1 NE2 REMARK 470 ARG A1008 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1019 CG CD CE NZ REMARK 470 THR A1021 OG1 CG2 REMARK 470 LYS A1043 CG CD CE NZ REMARK 470 GLU A1045 CG CD OE1 OE2 REMARK 470 ASP A1047 CG OD1 OD2 REMARK 470 ARG A1052 CG CD NE CZ NH1 NH2 REMARK 470 LEU A1066 CG CD1 CD2 REMARK 470 ASP A1072 CG OD1 OD2 REMARK 470 ARG A1080 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1083 CG CD CE NZ REMARK 470 GLU A1108 CG CD OE1 OE2 REMARK 470 LYS A1147 CG CD CE NZ REMARK 470 GLN A 263 CG CD OE1 NE2 REMARK 470 GLU A 294 CG CD OE1 OE2 REMARK 470 THR A 298 OG1 CG2 REMARK 470 ARG A 299 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 300 CG OD1 ND2 REMARK 470 SER A 301 OG REMARK 470 VAL A 370 CG1 CG2 REMARK 470 MET A 371 CG SD CE REMARK 470 ASP A 372 CG OD1 OD2 REMARK 470 ARG A 380 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 381 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 383 CG CD CE NZ REMARK 470 PHE A 385 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP A 417 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 417 CZ3 CH2 REMARK 470 ARG A 421 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 422 CG CD1 CD2 REMARK 470 SER B 136 OG REMARK 470 GLU B 138 CG CD OE1 OE2 REMARK 470 GLU B 139 CG CD OE1 OE2 REMARK 470 GLN B 140 CG CD OE1 NE2 REMARK 470 LEU B 141 CG CD1 CD2 REMARK 470 LEU B 142 CG CD1 CD2 REMARK 470 ARG B 170 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 192 CG CD1 CD2 REMARK 470 TRP B 203 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 203 CZ3 CH2 REMARK 470 LEU B 217 CG CD1 CD2 REMARK 470 LEU B 218 CG CD1 CD2 REMARK 470 SER B 219 OG REMARK 470 GLN B 221 CG CD OE1 NE2 REMARK 470 ASP B 222 CG OD1 OD2 REMARK 470 ARG B1008 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1019 CG CD CE NZ REMARK 470 THR B1021 OG1 CG2 REMARK 470 LYS B1043 CG CD CE NZ REMARK 470 GLU B1045 CG CD OE1 OE2 REMARK 470 ASP B1047 CG OD1 OD2 REMARK 470 ARG B1052 CG CD NE CZ NH1 NH2 REMARK 470 LEU B1066 CG CD1 CD2 REMARK 470 ASP B1072 CG OD1 OD2 REMARK 470 ARG B1080 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1083 CG CD CE NZ REMARK 470 GLU B1108 CG CD OE1 OE2 REMARK 470 LYS B1147 CG CD CE NZ REMARK 470 GLN B 263 CG CD OE1 NE2 REMARK 470 GLU B 294 CG CD OE1 OE2 REMARK 470 THR B 298 OG1 CG2 REMARK 470 ASN B 300 CG OD1 ND2 REMARK 470 MET B 371 CG SD CE REMARK 470 ARG B 380 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 381 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 383 CG CD CE NZ REMARK 470 PHE B 385 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP B 417 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 417 CZ3 CH2 REMARK 470 ARG B 421 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 422 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A1033 -97.26 -98.74 REMARK 500 SER A1038 102.89 -160.04 REMARK 500 ASN A1055 -30.09 74.45 REMARK 500 PHE A1114 46.82 -73.97 REMARK 500 LYS A1135 32.90 -84.57 REMARK 500 GLU A 292 50.27 -143.96 REMARK 500 SER A 301 82.67 -150.36 REMARK 500 ASN A 302 -57.04 -154.96 REMARK 500 ASN A 304 2.77 -66.49 REMARK 500 PHE A 367 42.26 -102.50 REMARK 500 PHE A 385 4.81 -69.41 REMARK 500 CYS A 403 -64.84 -147.09 REMARK 500 LEU B1033 -96.78 -98.80 REMARK 500 ASN B1055 -30.23 74.57 REMARK 500 PHE B1114 46.82 -74.03 REMARK 500 LYS B1135 32.65 -84.63 REMARK 500 LYS B 288 47.97 -86.48 REMARK 500 TYR B 289 -45.74 -157.86 REMARK 500 TRP B 297 43.84 70.39 REMARK 500 ASN B 302 -51.93 -152.65 REMARK 500 ASN B 304 2.79 -64.50 REMARK 500 PHE B 367 41.87 -102.42 REMARK 500 PHE B 385 4.93 -69.45 REMARK 500 CYS B 403 -64.68 -146.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 1203 REMARK 610 OLC B 1204 REMARK 610 OLC B 1205 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 97Y A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 97Y B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC B 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC B 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC B 1205 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VEX RELATED DB: PDB DBREF 5VEW A 128 257 UNP P43220 GLP1R_HUMAN 128 257 DBREF 5VEW A 1002 1161 UNP P00720 ENLYS_BPT4 2 161 DBREF 5VEW A 261 431 UNP P43220 GLP1R_HUMAN 261 431 DBREF 5VEW B 128 257 UNP P43220 GLP1R_HUMAN 128 257 DBREF 5VEW B 1002 1161 UNP P00720 ENLYS_BPT4 2 161 DBREF 5VEW B 261 431 UNP P43220 GLP1R_HUMAN 261 431 SEQADV 5VEW SER A 127 UNP P43220 EXPRESSION TAG SEQADV 5VEW CYS A 193 UNP P43220 SER 193 ENGINEERED MUTATION SEQADV 5VEW PHE A 196 UNP P43220 ILE 196 ENGINEERED MUTATION SEQADV 5VEW GLY A 212 UNP P43220 TYR 205 LINKER SEQADV 5VEW A UNP P43220 THR 207 DELETION SEQADV 5VEW A UNP P43220 ALA 208 DELETION SEQADV 5VEW A UNP P43220 ALA 209 DELETION SEQADV 5VEW A UNP P43220 GLN 210 DELETION SEQADV 5VEW A UNP P43220 GLN 211 DELETION SEQADV 5VEW A UNP P43220 HIS 212 DELETION SEQADV 5VEW A UNP P43220 GLN 213 DELETION SEQADV 5VEW GLY A 214 UNP P43220 TRP 214 LINKER SEQADV 5VEW ALA A 225 UNP P43220 SER 225 ENGINEERED MUTATION SEQADV 5VEW CSD A 233 UNP P43220 MET 233 ENGINEERED MUTATION SEQADV 5VEW GLY A 1012 UNP P00720 ARG 12 ENGINEERED MUTATION SEQADV 5VEW THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 5VEW ALA A 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 5VEW ARG A 1137 UNP P00720 ILE 137 ENGINEERED MUTATION SEQADV 5VEW ALA A 271 UNP P43220 SER 271 ENGINEERED MUTATION SEQADV 5VEW CYS A 317 UNP P43220 ILE 317 ENGINEERED MUTATION SEQADV 5VEW ILE A 318 UNP P43220 GLY 318 ENGINEERED MUTATION SEQADV 5VEW ALA A 346 UNP P43220 LYS 346 ENGINEERED MUTATION SEQADV 5VEW PHE A 347 UNP P43220 CYS 347 ENGINEERED MUTATION SEQADV 5VEW CYS A 361 UNP P43220 GLY 361 ENGINEERED MUTATION SEQADV 5VEW SER B 127 UNP P43220 EXPRESSION TAG SEQADV 5VEW CYS B 193 UNP P43220 SER 193 ENGINEERED MUTATION SEQADV 5VEW PHE B 196 UNP P43220 ILE 196 ENGINEERED MUTATION SEQADV 5VEW GLY B 212 UNP P43220 TYR 205 LINKER SEQADV 5VEW B UNP P43220 THR 207 DELETION SEQADV 5VEW B UNP P43220 ALA 208 DELETION SEQADV 5VEW B UNP P43220 ALA 209 DELETION SEQADV 5VEW B UNP P43220 GLN 210 DELETION SEQADV 5VEW B UNP P43220 GLN 211 DELETION SEQADV 5VEW B UNP P43220 HIS 212 DELETION SEQADV 5VEW B UNP P43220 GLN 213 DELETION SEQADV 5VEW GLY B 214 UNP P43220 TRP 214 LINKER SEQADV 5VEW ALA B 225 UNP P43220 SER 225 ENGINEERED MUTATION SEQADV 5VEW CSD B 233 UNP P43220 MET 233 ENGINEERED MUTATION SEQADV 5VEW GLY B 1012 UNP P00720 ARG 12 ENGINEERED MUTATION SEQADV 5VEW THR B 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 5VEW ALA B 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 5VEW ARG B 1137 UNP P00720 ILE 137 ENGINEERED MUTATION SEQADV 5VEW ALA B 271 UNP P43220 SER 271 ENGINEERED MUTATION SEQADV 5VEW CYS B 317 UNP P43220 ILE 317 ENGINEERED MUTATION SEQADV 5VEW ILE B 318 UNP P43220 GLY 318 ENGINEERED MUTATION SEQADV 5VEW ALA B 346 UNP P43220 LYS 346 ENGINEERED MUTATION SEQADV 5VEW PHE B 347 UNP P43220 CYS 347 ENGINEERED MUTATION SEQADV 5VEW CYS B 361 UNP P43220 GLY 361 ENGINEERED MUTATION SEQRES 1 A 455 SER GLU SER LYS ARG GLY GLU ARG SER SER PRO GLU GLU SEQRES 2 A 455 GLN LEU LEU PHE LEU TYR ILE ILE TYR THR VAL GLY TYR SEQRES 3 A 455 ALA LEU SER PHE SER ALA LEU VAL ILE ALA SER ALA ILE SEQRES 4 A 455 LEU LEU GLY PHE ARG HIS LEU HIS CYS THR ARG ASN TYR SEQRES 5 A 455 ILE HIS LEU ASN LEU PHE ALA SER PHE ILE LEU ARG ALA SEQRES 6 A 455 LEU CYS VAL PHE PHE LYS ASP ALA ALA LEU LYS TRP MET SEQRES 7 A 455 GLY SER GLY ASP GLY LEU LEU SER TYR GLN ASP SER LEU SEQRES 8 A 455 ALA CYS ARG LEU VAL PHE LEU LEU CSD GLN TYR CYS VAL SEQRES 9 A 455 ALA ALA ASN TYR TYR TRP LEU LEU VAL GLU GLY VAL TYR SEQRES 10 A 455 LEU TYR THR LEU LEU ALA PHE ASN ILE PHE GLU MET LEU SEQRES 11 A 455 ARG ILE ASP GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP SEQRES 12 A 455 THR GLU GLY TYR TYR THR ILE GLY ILE GLY HIS LEU LEU SEQRES 13 A 455 THR LYS SER PRO SER LEU ASN ALA ALA LYS SER GLU LEU SEQRES 14 A 455 ASP LYS ALA ILE GLY ARG ASN THR ASN GLY VAL ILE THR SEQRES 15 A 455 LYS ASP GLU ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP SEQRES 16 A 455 ALA ALA VAL ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS SEQRES 17 A 455 PRO VAL TYR ASP SER LEU ASP ALA VAL ARG ARG ALA ALA SEQRES 18 A 455 LEU ILE ASN MET VAL PHE GLN MET GLY GLU THR GLY VAL SEQRES 19 A 455 ALA GLY PHE THR ASN SER LEU ARG MET LEU GLN GLN LYS SEQRES 20 A 455 ARG TRP ASP GLU ALA ALA VAL ASN LEU ALA LYS SER ARG SEQRES 21 A 455 TRP TYR ASN GLN THR PRO ASN ARG ALA LYS ARG VAL ILE SEQRES 22 A 455 THR THR PHE ARG THR GLY THR TRP ASP ALA TYR SER GLU SEQRES 23 A 455 GLN TRP ILE PHE ARG LEU TYR VAL ALA ILE GLY TRP GLY SEQRES 24 A 455 VAL PRO LEU LEU PHE VAL VAL PRO TRP GLY ILE VAL LYS SEQRES 25 A 455 TYR LEU TYR GLU ASP GLU GLY CYS TRP THR ARG ASN SER SEQRES 26 A 455 ASN MET ASN TYR TRP LEU ILE ILE ARG LEU PRO ILE LEU SEQRES 27 A 455 PHE ALA CYS ILE VAL ASN PHE LEU ILE PHE VAL ARG VAL SEQRES 28 A 455 ILE CYS ILE VAL VAL SER LYS LEU LYS ALA ASN LEU MET SEQRES 29 A 455 CYS LYS THR ASP ILE ALA PHE ARG LEU ALA LYS SER THR SEQRES 30 A 455 LEU THR LEU ILE PRO LEU LEU CYS THR HIS GLU VAL ILE SEQRES 31 A 455 PHE ALA PHE VAL MET ASP GLU HIS ALA ARG GLY THR LEU SEQRES 32 A 455 ARG PHE ILE LYS LEU PHE THR GLU LEU SER PHE THR SER SEQRES 33 A 455 PHE GLN GLY LEU MET VAL ALA ILE LEU TYR CYS PHE VAL SEQRES 34 A 455 ASN ASN GLU VAL GLN LEU GLU PHE ARG LYS SER TRP GLU SEQRES 35 A 455 ARG TRP ARG LEU GLU HIS LEU HIS ILE GLN ARG ASP SER SEQRES 1 B 455 SER GLU SER LYS ARG GLY GLU ARG SER SER PRO GLU GLU SEQRES 2 B 455 GLN LEU LEU PHE LEU TYR ILE ILE TYR THR VAL GLY TYR SEQRES 3 B 455 ALA LEU SER PHE SER ALA LEU VAL ILE ALA SER ALA ILE SEQRES 4 B 455 LEU LEU GLY PHE ARG HIS LEU HIS CYS THR ARG ASN TYR SEQRES 5 B 455 ILE HIS LEU ASN LEU PHE ALA SER PHE ILE LEU ARG ALA SEQRES 6 B 455 LEU CYS VAL PHE PHE LYS ASP ALA ALA LEU LYS TRP MET SEQRES 7 B 455 GLY SER GLY ASP GLY LEU LEU SER TYR GLN ASP SER LEU SEQRES 8 B 455 ALA CYS ARG LEU VAL PHE LEU LEU CSD GLN TYR CYS VAL SEQRES 9 B 455 ALA ALA ASN TYR TYR TRP LEU LEU VAL GLU GLY VAL TYR SEQRES 10 B 455 LEU TYR THR LEU LEU ALA PHE ASN ILE PHE GLU MET LEU SEQRES 11 B 455 ARG ILE ASP GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP SEQRES 12 B 455 THR GLU GLY TYR TYR THR ILE GLY ILE GLY HIS LEU LEU SEQRES 13 B 455 THR LYS SER PRO SER LEU ASN ALA ALA LYS SER GLU LEU SEQRES 14 B 455 ASP LYS ALA ILE GLY ARG ASN THR ASN GLY VAL ILE THR SEQRES 15 B 455 LYS ASP GLU ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP SEQRES 16 B 455 ALA ALA VAL ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS SEQRES 17 B 455 PRO VAL TYR ASP SER LEU ASP ALA VAL ARG ARG ALA ALA SEQRES 18 B 455 LEU ILE ASN MET VAL PHE GLN MET GLY GLU THR GLY VAL SEQRES 19 B 455 ALA GLY PHE THR ASN SER LEU ARG MET LEU GLN GLN LYS SEQRES 20 B 455 ARG TRP ASP GLU ALA ALA VAL ASN LEU ALA LYS SER ARG SEQRES 21 B 455 TRP TYR ASN GLN THR PRO ASN ARG ALA LYS ARG VAL ILE SEQRES 22 B 455 THR THR PHE ARG THR GLY THR TRP ASP ALA TYR SER GLU SEQRES 23 B 455 GLN TRP ILE PHE ARG LEU TYR VAL ALA ILE GLY TRP GLY SEQRES 24 B 455 VAL PRO LEU LEU PHE VAL VAL PRO TRP GLY ILE VAL LYS SEQRES 25 B 455 TYR LEU TYR GLU ASP GLU GLY CYS TRP THR ARG ASN SER SEQRES 26 B 455 ASN MET ASN TYR TRP LEU ILE ILE ARG LEU PRO ILE LEU SEQRES 27 B 455 PHE ALA CYS ILE VAL ASN PHE LEU ILE PHE VAL ARG VAL SEQRES 28 B 455 ILE CYS ILE VAL VAL SER LYS LEU LYS ALA ASN LEU MET SEQRES 29 B 455 CYS LYS THR ASP ILE ALA PHE ARG LEU ALA LYS SER THR SEQRES 30 B 455 LEU THR LEU ILE PRO LEU LEU CYS THR HIS GLU VAL ILE SEQRES 31 B 455 PHE ALA PHE VAL MET ASP GLU HIS ALA ARG GLY THR LEU SEQRES 32 B 455 ARG PHE ILE LYS LEU PHE THR GLU LEU SER PHE THR SER SEQRES 33 B 455 PHE GLN GLY LEU MET VAL ALA ILE LEU TYR CYS PHE VAL SEQRES 34 B 455 ASN ASN GLU VAL GLN LEU GLU PHE ARG LYS SER TRP GLU SEQRES 35 B 455 ARG TRP ARG LEU GLU HIS LEU HIS ILE GLN ARG ASP SER HET CSD A 233 8 HET CSD B 233 8 HET 97Y A1201 37 HET OLC A1202 25 HET OLC A1203 19 HET OLA A1204 20 HET OLC B1201 25 HET 97Y B1202 37 HET OLC B1203 25 HET OLC B1204 19 HET OLC B1205 15 HETNAM CSD 3-SULFINOALANINE HETNAM 97Y N-{4-[(R)-(3,3-DIMETHYLCYCLOBUTYL)({6-[4- HETNAM 2 97Y (TRIFLUOROMETHYL)-1H-IMIDAZOL-1-YL]PYRIDIN-3- HETNAM 3 97Y YL}AMINO)METHYL]BENZENE-1-CARBONYL}-BETA-ALANINE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLA OLEIC ACID HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 3 97Y 2(C26 H28 F3 N5 O3) FORMUL 4 OLC 6(C21 H40 O4) FORMUL 6 OLA C18 H34 O2 FORMUL 12 HOH *20(H2 O) HELIX 1 AA1 SER A 136 PHE A 169 1 34 HELIX 2 AA2 ARG A 170 HIS A 173 5 4 HELIX 3 AA3 CYS A 174 ALA A 200 1 27 HELIX 4 AA4 SER A 223 PHE A 257 1 35 HELIX 5 AA5 ASN A 1002 GLY A 1012 1 11 HELIX 6 AA6 SER A 1038 ALA A 1049 1 12 HELIX 7 AA7 THR A 1059 ARG A 1080 1 22 HELIX 8 AA8 LEU A 1084 LEU A 1091 1 8 HELIX 9 AA9 ASP A 1092 MET A 1106 1 15 HELIX 10 AB1 GLY A 1107 ALA A 1112 1 6 HELIX 11 AB2 PHE A 1114 GLN A 1123 1 10 HELIX 12 AB3 ARG A 1125 LYS A 1135 1 11 HELIX 13 AB4 SER A 1136 THR A 1142 1 7 HELIX 14 AB5 THR A 1142 GLY A 1156 1 15 HELIX 15 AB6 TRP A 1158 SER A 261 5 5 HELIX 16 AB7 GLU A 262 TRP A 274 1 13 HELIX 17 AB8 TRP A 274 GLU A 292 1 19 HELIX 18 AB9 TRP A 306 ALA A 337 1 32 HELIX 19 AC1 ASP A 344 PHE A 367 1 24 HELIX 20 AC2 PHE A 381 PHE A 385 1 5 HELIX 21 AC3 THR A 386 CYS A 403 1 18 HELIX 22 AC4 ASN A 406 LEU A 422 1 17 HELIX 23 AC5 PRO B 137 PHE B 169 1 33 HELIX 24 AC6 ARG B 170 HIS B 173 5 4 HELIX 25 AC7 CYS B 174 ALA B 200 1 27 HELIX 26 AC8 SER B 223 PHE B 257 1 35 HELIX 27 AC9 ASN B 1002 GLY B 1012 1 11 HELIX 28 AD1 SER B 1038 ALA B 1049 1 12 HELIX 29 AD2 THR B 1059 ARG B 1080 1 22 HELIX 30 AD3 LEU B 1084 LEU B 1091 1 8 HELIX 31 AD4 ASP B 1092 MET B 1106 1 15 HELIX 32 AD5 GLY B 1107 ALA B 1112 1 6 HELIX 33 AD6 PHE B 1114 GLN B 1123 1 10 HELIX 34 AD7 ARG B 1125 LYS B 1135 1 11 HELIX 35 AD8 SER B 1136 THR B 1142 1 7 HELIX 36 AD9 THR B 1142 GLY B 1156 1 15 HELIX 37 AE1 TRP B 1158 SER B 261 5 5 HELIX 38 AE2 GLU B 262 TRP B 274 1 13 HELIX 39 AE3 TRP B 274 TYR B 291 1 18 HELIX 40 AE4 TRP B 306 ALA B 337 1 32 HELIX 41 AE5 ASP B 344 PHE B 367 1 24 HELIX 42 AE6 PHE B 381 PHE B 385 1 5 HELIX 43 AE7 THR B 386 CYS B 403 1 18 HELIX 44 AE8 ASN B 406 LEU B 422 1 17 SHEET 1 AA1 3 ARG A1014 LYS A1019 0 SHEET 2 AA1 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 AA1 3 HIS A1031 LEU A1032 -1 O HIS A1031 N ILE A1027 SHEET 1 AA2 3 ARG B1014 LYS B1019 0 SHEET 2 AA2 3 TYR B1025 GLY B1028 -1 O THR B1026 N TYR B1018 SHEET 3 AA2 3 HIS B1031 LEU B1032 -1 O HIS B1031 N ILE B1027 SSBOND 1 CYS A 226 CYS A 296 1555 1555 2.03 SSBOND 2 CYS A 317 CYS A 361 1555 1555 2.05 SSBOND 3 CYS B 226 CYS B 296 1555 1555 2.03 SSBOND 4 CYS B 317 CYS B 361 1555 1555 2.05 LINK C LEU A 232 N CSD A 233 1555 1555 1.36 LINK C CSD A 233 N GLN A 234 1555 1555 1.35 LINK C LEU B 232 N CSD B 233 1555 1555 1.36 LINK C CSD B 233 N GLN B 234 1555 1555 1.35 SITE 1 AC1 12 VAL A 331 PHE A 347 ARG A 348 LYS A 351 SITE 2 AC1 12 SER A 352 THR A 355 LEU A 401 VAL A 405 SITE 3 AC1 12 ASN A 406 OLC A1203 ILE B 286 OLC B1201 SITE 1 AC2 7 SER A 163 TYR A 178 LEU A 181 ASN A 182 SITE 2 AC2 7 ILE A 188 PHE A 266 OLA A1204 SITE 1 AC3 2 LYS A 342 97Y A1201 SITE 1 AC4 2 HIS A 173 OLC A1202 SITE 1 AC5 6 PHE A 324 THR A 362 97Y A1201 LEU B 278 SITE 2 AC5 6 LEU B 279 VAL B 282 SITE 1 AC6 13 ILE A 286 VAL B 331 PHE B 347 ARG B 348 SITE 2 AC6 13 LYS B 351 SER B 352 THR B 355 MET B 397 SITE 3 AC6 13 LEU B 401 VAL B 405 ASN B 406 OLC B1203 SITE 4 AC6 13 OLC B1205 SITE 1 AC7 6 LEU A 278 LEU A 279 VAL A 282 THR B 362 SITE 2 AC7 6 GLU B 387 97Y B1202 SITE 1 AC8 4 SER B 163 TYR B 178 ASN B 182 PHE B 266 SITE 1 AC9 2 LYS B 342 97Y B1202 CRYST1 64.770 66.430 83.440 90.54 90.18 107.73 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015439 0.004936 0.000102 0.00000 SCALE2 0.000000 0.015804 0.000172 0.00000 SCALE3 0.000000 0.000000 0.011985 0.00000